This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Txcell. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Brigitte Quatannens: Pioneering Therapeutic Innovations in Cell Therapy
Introduction
Brigitte Quatannens is an accomplished inventor based in Mandelieu-la-Napoule, France. With a focus on advancements in cell therapy, she is recognized for her innovative approach in the biomedical field. Her work has the potential to significantly improve patient outcomes through targeted therapies.
Latest Patents
Brigitte holds a patent for a method titled "Method for Assessing the Efficacy of a TR1 Cell Therapy in a Subject." This groundbreaking method assesses a patient's response to antigen-specific Tr1 cell therapy. It involves determining the antigen-specific proliferation of T cells from a patient’s cell sample and comparing this proliferation to a standard reference. This technique helps in evaluating whether a patient is effectively responding to the treatment.
Career Highlights
Brigitte Quatannens has achieved notable recognition in her field through her pivotal patent and contributions to cell therapy. Her role at Txcell, a company focused on advanced cellular immunotherapy, has enabled her to extend her research and develop innovative therapeutic solutions.
Collaborations
In her journey, Brigitte collaborates closely with Arnaud Foussat, a fellow expert and colleague. Their partnership continues to drive innovation within Txcell, enhancing the research and development of cell therapies that aim to transform patient care.
Conclusion
With a focus on improving the efficacy of cell therapies, Brigitte Quatannens exemplifies the spirit of innovation in biomedical research. Her contributions not only advance scientific understanding but also provide hope for patients undergoing treatment. As she continues her work with Txcell, her impact on the field is sure to grow, inspiring future innovations in medicine.